Results 151 to 160 of about 740,134 (361)

Meat Slaughter and Processing Plants’ Traceability Levels Evidence From Iowa [PDF]

open access: yes
In the United States (U.S.), there is no uniform traceability regulation across food sector. Food and Drug Administration (FDA) implemented one-step back and one-step forward traceability over the industries under its jurisdiction. U.S.
Bulut, Harun, Lawrence, John D.
core   +1 more source

Development of a targeted and controlled nanoparticle delivery system for FoxO1 inhibitors [PDF]

open access: yes, 2020
Background: Poly (lactic-co-glycolic acid) (PLGA) and polyethylene glycol (PEG) are polymers approved by the United States’ Food and Drug Administration.
Cheng, Zhiyong   +5 more
core   +1 more source

A network of regulatory innovations to improve FDA quality assessments of human drug applications

open access: yesInternational Journal of Pharmaceutics: X
A network of regulatory innovations brings a holistic approach to improving the submission, assessment, and lifecycle management of pharmaceutical quality information in the U.S. This dedicated effort in the FDA’s Center for Drug Evaluation and Research (
Russie Tran   +10 more
doaj  

Listeria monocytogenes Growth Kinetics in Milkshakes Made from Naturally and Artificially Contaminated Ice Cream

open access: yesFrontiers in Microbiology, 2018
This study assessed the growth of Listeria monocytogenes in milkshakes made using the process-contaminated ice cream associated with a listeriosis outbreak in comparison to milkshakes made with artificially contaminated ice cream.
Joelle K. Salazar   +6 more
doaj   +1 more source

Transforming Cellulose Into Functional Three‐Dimensional Structures

open access: yesAdvanced Functional Materials, EarlyView.
Cellulose is promising for replacing synthetic polymers due to its excellent mechanical properties and low cost. This review highlights the recent advancements in transforming cellulose into functional 3D structures, including liquid gels and porous materials.
Xia Sun   +5 more
wiley   +1 more source

The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. [PDF]

open access: yes, 2020
Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed.
Ballas, Samir K
core   +1 more source

Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans

open access: yesFrontiers in Toxicology
Consumer use of cannabidiol (CBD) is growing, but there are still data gaps regarding its possible adverse effects on reproduction and development.
Jessica A. Camacho   +9 more
doaj   +1 more source

The United States Food and Drug Administration’s Platform Technology Designation to Expedite the Development of Drugs

open access: yesPharmaceutics
Drug development costs can be significantly reduced if proven “platform” technologies are allowed to be used without having to validate their use. The most recent US Food and Drug Administration (FDA) guideline brings more clarity, as well as a greater focus on the most complex technologies that can now be used for faster drug development.
openaire   +3 more sources

Anionic Citrate‐Based 3D‐Printed Scaffolds for Tunable and Sustained Orthobiologic Delivery to Enhance Tissue Regeneration

open access: yesAdvanced Functional Materials, EarlyView.
A potent anionic citric acid‐based 3D‐printed scaffold is developed for the sustained and controlled release of orthobiologics to enhance orthopedic therapeutic efficacy. Comprehensive in vivo studies demonstrated effective bone fusion and high safety at a low dose of BMP‐2 delivered by the system, establishing it as a promising platform for safe ...
Se‐Hwan Lee   +12 more
wiley   +1 more source

The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief? [PDF]

open access: yes, 2012
Tylenol. Advil. Monistat 7. Imodium AD. These are some of the most commonly used, widely available, and successful drugs in the United States. All of them began as drugs only available by a prescription. All of them made a successful prescription-only to
Kisloff, Michelle A.
core  

Home - About - Disclaimer - Privacy